#	Pagina
attuale pagina	/open-h2020/projects/197040/index.html

Opendata, web and dolomites

CIRDvalid

CIRDvalid – Clinical validation of a set of 11 biomarkers and a system of diagnostic and therapeutical devices for the resuscitation of patients suffering from long-lasting cardiac arrest

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

CIRDvalid project word cloud

Explore the words cloud of the CIRDvalid project. It provides you a very rough idea of what is the project "CIRDvalid" about.

decades device planning for hospital suffering feasibility perform reimbursement validation clinical 3 successful shift cird 18 damage certification verification neurological significantly approval arrest validated therapy medical 90 strategy medicine milestones businessplan body ce cardiac humans preclinical improvement resuscitation 11 animal proof elaboration reperfusion centres market leadership pigs animals therapeutical nearly induce innovative frame time minutes survive biom innovation biomarkers patients roadmap emergency 15 diagnostic paradigmatic resuscitec

Project "CIRDvalid" data sheet

The following table provides information about the project.

Coordinator	RESUSCITEC GMBH Organization address address: ROTTECKRING 4 city: FREIBURG IM BREISGAU postcode: 79098 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Germany [DE]
Project website	http://www.resuscitec.de
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-SMEINST-1-2015
Funding Scheme	SME-1
Starting year	2015
Duration (year-month-day)	from 2015-06-01 to 2015-09-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	RESUSCITEC GMBH RESUSCITEC GMBH Organization address address: ROTTECKRING 4 city: FREIBURG IM BREISGAU postcode: 79098 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (FREIBURG IM BREISGAU)	coordinator	50˙000.00

Map

Project objective

For decades there has been no significant improvement in resuscitation-therapy of patients suffering from cardiac arrest. Only 3% survive out-of-hospital and only 18% survive in-hospital resuscitation. The time-frame for a successful resuscitation is only about 3 to 5 minutes after cardiac arrest. To increase this time-frame significantly ResuSciTec has developed a new therapeutical concept to induce a paradigmatic shift in resuscitation therapy. This new concept called “controlled whole body reperfusion” is based on a set of 11 known biomarkers which have been validated in animal studies. ResuSciTec has produced proof of concept in preclinical animal studies for successful resuscitation after 20 minutes of cardiac arrest. About 90% of the animals (pigs) survive without or nearly without neurological damage. To perform this new therapy ResuSciTec has developed an innovative Diagnostic Medical Device for measurement of the 11 biomarkers called “BioM-11”. This Device will be integrated in an innovative therapeutical system called “CIRD - Controlled Integrated Resuscitation Device”. The proposed feasibility study (Phase 1) will provide: (1) planning of clinical studies (2) Verification and Validation planning for the devices (3) elaboration of a businessplan including milestones, market-study, roadmap for certification and reimbursement strategy. The overall innovation project (Phase 2) has four objectives: (1) Clinical validation of 11 biomarkers in humans for resuscitation-therapy in clinical studies (2) validation and CE-approval of the diagnostic device BioM-11 (3) validation and CE-approval of the CIRD 2.0-system for the resuscitation of patients (4) Clinical validation of the CIRD 2.0-system in-hospital and out-of hospital in 10 to 15 clinical centres in Europe to provide evidence for the new therapy called “controlled whole body reperfusion”. The overall project aims to show European leadership in this important field of emergency medicine.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CIRDVALID" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CIRDVALID" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

RESHAPE (2019)

Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials

DIAdIC (2019)

Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial